{
  "issues": [
    "Current MAP is 59 mmHg (hypotensive); contrast administration for CTPA is unsafe until MAP ≥ 65 mmHg is achieved.",
    "Renal function shows creatinine 1.7 mg/dL and eGFR 59 mL/min/1.73 m², placing the patient at moderate risk for contrast‑induced nephropathy, especially in the setting of hypotension.",
    "Weight, height, and therefore BMI are missing, preventing accurate weight‑based contrast volume calculation and personalized hydration protocols.",
    "Renal tool summary incorrectly states \"Missing BMI or creatinine\" even though creatinine is present; the comment about missing lab timestamps limits confidence in the risk assessment.",
    "Agent 2’s renal safety note references an eGFR cutoff of <30 mL/min/1.73 m², which does not directly apply to this patient (eGFR 59), but the note does not emphasize the additional risk conferred by hypotension.",
    "No explicit plan for immediate hemodynamic optimization (e.g., fluid bolus, vasopressor) prior to imaging is provided."
  ],
  "recommendations": [
    "Stabilize the patient hemodynamically first: aim for MAP ≥ 65 mmHg using IV crystalloid bolus (e.g., 500 mL normal saline) and, if needed, vasopressor support before any contrast‑enhanced study.",
    "If MAP cannot be reliably achieved within a short time frame, defer CTPA and perform a ventilation‑perfusion (V/Q) scan as the primary imaging modality for suspected pulmonary embolism.",
    "Obtain accurate weight and height now; calculate BMI to guide contrast volume (typically 1.5 mL/kg for low‑volume protocols) and hydration dosing (e.g., 1 mL/kg/hr isotonic saline for 12 h before and after contrast).",
    "When CTPA is deemed necessary after stabilization, use a low‑osmolar or iso‑osmolar iodinated contrast agent, limit total volume to the lowest effective amount, and consider a split‑dose or diluted protocol if feasible.",
    "Implement renal protection measures: IV isotonic hydration (1 mL/kg/hr beginning 12 h pre‑scan and continuing 6–12 h post‑scan) ± bicarbonate infusion if patient is acidotic, and avoid nephrotoxic medications.",
    "Schedule repeat renal labs (serum creatinine and eGFR) at 24 h and 48 h post‑contrast to detect any acute kidney injury.",
    "Document the contraindication (hypotension) and the mitigation steps taken in the radiology order set.",
    "Consider alternative bedside diagnostics (e.g., focused cardiac ultrasound, lower‑extremity Doppler) if imaging cannot be performed promptly."
  ],
  "confidence": 0.78,
  "agent2_confidence": 0.78,
  "timestamp": "2025-09-09T06:08:59.050770Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-09T06:08:21.925614Z",
          "priority": "critical",
          "value": 59.0,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-09T06:08:21.925649Z",
          "priority": "critical",
          "value": 1.7,
          "status": "fail",
          "reason": "Creatinine significantly elevated."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-09T06:08:21.925667Z",
          "priority": "important",
          "value": 20.0,
          "status": "warning",
          "reason": "BUN/Cr ratio suggests prerenal azotemia."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-09T06:08:21.925695Z",
          "priority": "important",
          "value": 4.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "Creatinine significantly elevated.",
          "BUN/Cr ratio suggests prerenal azotemia.",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-09T06:08:21.925783Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Current MAP is 59 mmHg (hypotensive); contrast administration for CTPA is unsafe until MAP ≥ 65 mmHg is achieved.\",\n    \"Renal function shows creatinine 1.7 mg/dL and eGFR 59 mL/min/1.73 m², placing the patient at moderate risk for contrast‑induced nephropathy, especially in the setting of hypotension.\",\n    \"Weight, height, and therefore BMI are missing, preventing accurate weight‑based contrast volume calculation and personalized hydration protocols.\",\n    \"Renal tool summary incorrectly states \\\"Missing BMI or creatinine\\\" even though creatinine is present; the comment about missing lab timestamps limits confidence in the risk assessment.\",\n    \"Agent 2’s renal safety note references an eGFR cutoff of <30 mL/min/1.73 m², which does not directly apply to this patient (eGFR 59), but the note does not emphasize the additional risk conferred by hypotension.\",\n    \"No explicit plan for immediate hemodynamic optimization (e.g., fluid bolus, vasopressor) prior to imaging is provided.\"\n  ],\n  \"recommendations\": [\n    \"Stabilize the patient hemodynamically first: aim for MAP ≥ 65 mmHg using IV crystalloid bolus (e.g., 500 mL normal saline) and, if needed, vasopressor support before any contrast‑enhanced study.\",\n    \"If MAP cannot be reliably achieved within a short time frame, defer CTPA and perform a ventilation‑perfusion (V/Q) scan as the primary imaging modality for suspected pulmonary embolism.\",\n    \"Obtain accurate weight and height now; calculate BMI to guide contrast volume (typically 1.5 mL/kg for low‑volume protocols) and hydration dosing (e.g., 1 mL/kg/hr isotonic saline for 12 h before and after contrast).\",\n    \"When CTPA is deemed necessary after stabilization, use a low‑osmolar or iso‑osmolar iodinated contrast agent, limit total volume to the lowest effective amount, and consider a split‑dose or diluted protocol if feasible.\",\n    \"Implement renal protection measures: IV isotonic hydration (1 mL/kg/hr beginning 12 h pre‑scan and continuing 6–12 h post‑scan) ± bicarbonate infusion if patient is acidotic, and avoid nephrotoxic medications.\",\n    \"Schedule repeat renal labs (serum creatinine and eGFR) at 24 h and 48 h post‑contrast to detect any acute kidney injury.\",\n    \"Document the contraindication (hypotension) and the mitigation steps taken in the radiology order set.\",\n    \"Consider alternative bedside diagnostics (e.g., focused cardiac ultrasound, lower‑extremity Doppler) if imaging cannot be performed promptly.\"\n  ],\n  \"confidence\": 0.78\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Current MAP is 59 mmHg (hypotensive); contrast administration for CTPA is unsafe until MAP ≥ 65 mmHg is achieved.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal function shows creatinine 1.7 mg/dL and eGFR 59 mL/min/1.73 m², placing the patient at moderate risk for contrast‑induced nephropathy, especially in the setting of hypotension.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Weight, height, and therefore BMI are missing, preventing accurate weight‑based contrast volume calculation and personalized hydration protocols.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Renal tool summary incorrectly states \"Missing BMI or creatinine\" even though creatinine is present; the comment about missing lab timestamps limits confidence in the risk assessment.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2’s renal safety note references an eGFR cutoff of <30 mL/min/1.73 m², which does not directly apply to this patient (eGFR 59), but the note does not emphasize the additional risk conferred by hypotension.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "No explicit plan for immediate hemodynamic optimization (e.g., fluid bolus, vasopressor) prior to imaging is provided.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Stabilize the patient hemodynamically first: aim for MAP ≥ 65 mmHg using IV crystalloid bolus (e.g., 500 mL normal saline) and, if needed, vasopressor support before any contrast‑enhanced study.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '0'"
      },
      {
        "text": "If MAP cannot be reliably achieved within a short time frame, defer CTPA and perform a ventilation‑perfusion (V/Q) scan as the primary imaging modality for suspected pulmonary embolism.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain accurate weight and height now; calculate BMI to guide contrast volume (typically 1.5 mL/kg for low‑volume protocols) and hydration dosing (e.g., 1 mL/kg/hr isotonic saline for 12 h before and after contrast).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "When CTPA is deemed necessary after stabilization, use a low‑osmolar or iso‑osmolar iodinated contrast agent, limit total volume to the lowest effective amount, and consider a split‑dose or diluted protocol if feasible.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Implement renal protection measures: IV isotonic hydration (1 mL/kg/hr beginning 12 h pre‑scan and continuing 6–12 h post‑scan) ± bicarbonate infusion if patient is acidotic, and avoid nephrotoxic medications.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Schedule repeat renal labs (serum creatinine and eGFR) at 24 h and 48 h post‑contrast to detect any acute kidney injury.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document the contraindication (hypotension) and the mitigation steps taken in the radiology order set.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "hemodynamic instability supported by MAP 59.0"
      },
      {
        "text": "Consider alternative bedside diagnostics (e.g., focused cardiac ultrasound, lower‑extremity Doppler) if imaging cannot be performed promptly.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 14,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 0,
      "contradicted": 0
    },
    "hallucination_score": 0.0,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.0
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 20028931.0,
        "age": 72.0,
        "hadm_id": 34567891.0,
        "creatinine_mg_dl": 1.7,
        "bun_mg_dl": 34.0,
        "glucose_mg_dl": 142.0,
        "hemoglobin_g_dl": 10.1,
        "hematocrit_pct": 30.5,
        "platelet_count": 210.0,
        "wbc_count": 12.3,
        "sodium_meq_l": 135.0,
        "potassium_mmol_l": 4.6,
        "chloride_meq_l": 100.0,
        "bicarbonate_meq_l": 21.0,
        "egfr_ckd_epi": 59.0,
        "heart_rate_bpm": 95.0,
        "systolic_bp_mmhg": 82.0,
        "diastolic_bp_mmhg": 48.0,
        "map_mmhg": 59.0,
        "pulse_pressure_mmhg": 34.0,
        "temperature_f": 98.9,
        "spo2_pct": 94.0,
        "respiratory_rate": 22.0,
        "bun_creatinine_ratio": 20.0,
        "hospital_expire_flag": 0.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "white",
        "0",
        "21",
        "f",
        "30.5",
        "1.7",
        "other",
        "95",
        "20.0",
        "potassium_mmol_l"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Current MAP is 59 mmHg (hypotensive); contrast administration for CTPA is unsafe until MAP ≥ 65 mmHg is achieved.",
      "Renal function shows creatinine 1.7 mg/dL and eGFR 59 mL/min/1.73 m², placing the patient at moderate risk for contrast‑induced nephropathy, especially in the setting of hypotension.",
      "Weight, height, and therefore BMI are missing, preventing accurate weight‑based contrast volume calculation and personalized hydration protocols.",
      "Renal tool summary incorrectly states \"Missing BMI or creatinine\" even though creatinine is present; the comment about missing lab timestamps limits confidence in the risk assessment.",
      "Agent 2’s renal safety note references an eGFR cutoff of <30 mL/min/1.73 m², which does not directly apply to this patient (eGFR 59), but the note does not emphasize the additional risk conferred by hypotension.",
      "No explicit plan for immediate hemodynamic optimization (e.g., fluid bolus, vasopressor) prior to imaging is provided."
    ],
    "recommendations": [
      "Stabilize the patient hemodynamically first: aim for MAP ≥ 65 mmHg using IV crystalloid bolus (e.g., 500 mL normal saline) and, if needed, vasopressor support before any contrast‑enhanced study.",
      "If MAP cannot be reliably achieved within a short time frame, defer CTPA and perform a ventilation‑perfusion (V/Q) scan as the primary imaging modality for suspected pulmonary embolism.",
      "Obtain accurate weight and height now; calculate BMI to guide contrast volume (typically 1.5 mL/kg for low‑volume protocols) and hydration dosing (e.g., 1 mL/kg/hr isotonic saline for 12 h before and after contrast).",
      "When CTPA is deemed necessary after stabilization, use a low‑osmolar or iso‑osmolar iodinated contrast agent, limit total volume to the lowest effective amount, and consider a split‑dose or diluted protocol if feasible.",
      "Implement renal protection measures: IV isotonic hydration (1 mL/kg/hr beginning 12 h pre‑scan and continuing 6–12 h post‑scan) ± bicarbonate infusion if patient is acidotic, and avoid nephrotoxic medications.",
      "Schedule repeat renal labs (serum creatinine and eGFR) at 24 h and 48 h post‑contrast to detect any acute kidney injury.",
      "Document the contraindication (hypotension) and the mitigation steps taken in the radiology order set.",
      "Consider alternative bedside diagnostics (e.g., focused cardiac ultrasound, lower‑extremity Doppler) if imaging cannot be performed promptly."
    ],
    "confidence": 0.78
  }
}